Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 3Unknown 2Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 5Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Neoplasms 1Esophageal Neoplasms 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Endosonography × Clear all
NCT02863783 2023-03-06

EUS Fiducial for Pancreas Surgery

University of Southern California

Phase NA Unknown
20 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01555801 2017-01-25

Endoscopic Ultrasound Plus Submucosal Injection for Early Esophageal Cancer

Sun Yat-sen University

Phase NA Unknown
80 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡